Ocular Complications Related to Iris-Fixated Phakic Intraocular Lens Implantation: A Systematic Review and Meta-Analysis
TOPIC: This systematic review and meta-analysis evaluated the cumulative prevalence of ocular complications following implantation of Artisan®/Verisyse® iris-fixated phakic intraocular lenses in adult patients undergoing refractive surgery. Outcomes included postoperative ocular complications and longitudinal loss of endothelial cell density (ECD). CLINICAL RELEVANCE: Phakic intraocular lenses are widely used to correct moderate-to-high refractive errors. Available evidence on complication rates is heterogeneous and often limited to narrative reports, hindering accurate risk counseling and long-term clinical decision-making. METHODS: This study was conducted according to PRISMA guidelines and was registered in PROSPERO (CRD420251150677). Eligible studies included ≥10 eyes implanted with Artisan®/Verisyse® lenses reporting postoperative complications. Risk of bias was assessed using design-specific tools. Proportion meta-analyses were performed with subgroup analyses comparing real-world evidence studies versus clinical trials. ECD loss was analyzed from three months to 10 years post-implantation. Certainty of evidence was evaluated using GRADE. RESULTS: Fifty-five studies were included. Iris atrophy was the most common complication (20.3%, 95% CI: 5.7-52.1). Other complications included pupil ovalization (7.6%, 95% CI: 4.8-12.5), progressive reduction in visual acuity (7.6%, 95% CI: 5.8-9.5), position-related complications (including rotation, dislocation, subluxation, and luxation) (6.7%, 95% CI: 1.9-33.4), uveitis (6.2%, 95% CI: 4.3-9.1), and halos (5.3%, 95% CI: 3.2-7.9). Ocular hypertension (4.7%, 95% CI: 2.4-7.9), cataract (2.8%, 95% CI: 1.6-3.5), corneal decompensation (2.6%, 95% CI: 1.8-6.5), and retinal detachment (1.1%, 95% CI: 0.7-1.3) occurred less frequently. Subgroup analyses showed higher rates of corneal decompensation in real-world studies (4.2% vs. 1.3%; p = 0.04) and traumatic position-related complications (5.0% vs. 0.8%; p = 0.02), whereas ocular hypertension was more frequent in clinical trials (14.1% vs. 2.3%; p < 0.01). ECD loss increased from 5.3% at 3 months to 15.8% at 10 years. Certainty of evidence ranged from very low to moderate, with substantial heterogeneity across outcomes. CONCLUSION: Despite overall acceptable safety, Artisan®/Verisyse® implantation is associated with measurable ocular complications and progressive ECD loss.
Authors
- Danna Lesley Cruz Reyes (ORCID: https://orcid.org/0000-0002-5977-8162)
- Paula Alejandra Navarro (ORCID: https://orcid.org/0000-0003-2191-033X)
- Lizeth Catherine Rodríguez-Corredor (ORCID: https://orcid.org/0000-0002-1338-3405)
- Germán Mejía‐Salgado (ORCID: https://orcid.org/0000-0002-1241-0715)
- Alejandro Tello (ORCID: https://orcid.org/0000-0001-5081-0720)
- Rubén D. Berrospi (ORCID: https://orcid.org/0000-0001-6877-4182)
- Juan Daniel Ribero (ORCID: https://orcid.org/0000-0003-4877-5449)
- Diana Carolina Cortés Jaimes (ORCID: https://orcid.org/0009-0007-6086-917X)
- Joaquín Alonso Pérez-Vivas
- Laura Daniela Rodríguez-Camelo (ORCID: https://orcid.org/0009-0006-4646-6991)
- Blanca Aguilar-Barrera (ORCID: https://orcid.org/0009-0008-8673-4801)
- Santiago Espinosa-Lugo (ORCID: https://orcid.org/0009-0008-0956-8758)
- Virgilio Galvis
- Ana María Núñez-Pardo (ORCID: https://orcid.org/0000-0003-3611-5582)
Institutions
- Universidad Industrial de Santander (CO)
- Universidad Autónoma de Bucaramanga (CO)
- Universidad Nacional de Colombia (CO)
- Foscal Hospital (CO)
- Universidad del Rosario (CO)
Publication Details
- Journal
- Journal of Cataract & Refractive Surgery
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1097/j.jcrs.0000000000002110
- Primary Topic
- Intraocular Surgery and Lenses
- Type
- article
- Field-Weighted Citation Impact
- 0.00